Torthaí cuardaigh - Suzanne Cheng
- 1 - 8 toradh as 8 á dtaispeáint
-
1
Interventions for erosive lichen planus affecting mucosal sites de réir Suzanne Cheng, Gudula Kirtschig, Susan M. Cooper, Martin H. Thornhill, Jo Leonardi‐Bee, Ruth Murphy
Foilsithe / Cruthaithe 2012Revisão -
2
Genetic Polymorphisms and Cerebral Palsy in Very Preterm Infants de réir Karin B. Nelson, James M. Dambrosia, David M. Iovannisci, Suzanne Cheng, Judith K. Grether, Edward J. Lammer
Foilsithe / Cruthaithe 2005Artigo -
3
Gene interactions and stroke risk in children with sickle cell anemia de réir Carolyn Hoppe, William Klitz, Suzanne Cheng, R. Apple, Lori Steiner, Robles Lara, Tom Girard, Elliott Vichinsky, Lori Styles
Foilsithe / Cruthaithe 2003Artigo -
4
Alanine for Proline Substitution in the Peroxisome Proliferator–Activated Receptor Gamma-2 (PPARG2) Gene and the Risk of Incident Myocardial Infarction de réir Paul M. Ridker, Nancy R. Cook, Suzanne Cheng, M Kellis, Klaus Lindpaintner, Jorge Plutzky, Robert Y.L. Zee
Foilsithe / Cruthaithe 2003Artigo -
5
Confirmation of an Association Between the TNF(−308) Promoter Polymorphism and Stroke Risk in Children With Sickle Cell Anemia de réir Carolyn Hoppe, William Klitz, Katherine D’Harlingue, Suzanne Cheng, Michael Grow, Lori Steiner, Janelle A. Noble, Robert J. Adams, Lori Styles
Foilsithe / Cruthaithe 2007Artigo -
6
A Multilocus Genotyping Assay for Candidate Markers of Cardiovascular Disease Risk de réir Suzanne Cheng, Michael Grow, Céline Pallaud, William Klitz, M Kellis, Sophia Visvikis, John J. Chen, Clive R. Pullinger, Mary J. Malloy, Gérard Siest, John P. Kane
Foilsithe / Cruthaithe 1999Artigo -
7
A Meta-Analysis of Candidate Gene Polymorphisms and Ischemic Stroke in 6 Study Populations de réir Xingyu Wang, Suzanne Cheng, Victoria H. Brophy, M Kellis, Christine Mannhalter, Klaus Berger, Wolfgang Lalouschek, Warren S. Browner, Yu Shi, E. Bernd Ringelstein, Christof Kessler, Jan Luedemann, Klaus Lindpaintner, Lisheng Liu, Paul M. Ridker, Robert Y.L. Zee, Nancy R. Cook
Foilsithe / Cruthaithe 2009Revisão -
8
Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study de réir Grant A. McArthur, Paul B. Chapman, Caroline Robert, James Larkin, John B.A.G. Haanen, Reinhard Dummer, Antoni Ribas, David Hogg, Omid Hamid, Paolo A. Ascierto, Claus Garbe, Alessandro Testori, Michele Maio, Paul Lorigan, Célèste Lebbé, Thomas Jouary, Dirk Schadendorf, S. O'Day, John M. Kirkwood, Alexander M.M. Eggermont, Brigitte Dréno, Jeffrey A. Sosman, Keith T. Flaherty, Ming Yin, Ivor Caro, Suzanne Cheng, Kerstin Trunzer, Axel Hauschild
Foilsithe / Cruthaithe 2014Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Internal medicine
Medicine
Biology
Gene
Genetics
Disease
Engineering
Environmental health
Mechanical engineering
Population
Stroke (engine)
Bioinformatics
Candidate gene
Endocrinology
Genotype
Haplotype
Ischemia
Ischemic stroke
Odds ratio
Sickle cell anemia
Allele
Anemia
Cancer
Cancer research
Cardiology
Chemotherapy
Clinical trial
Cochrane Library
Cohort
Dacarbazine